2019 Annual MIS Brochure

This annual summary presents the results of mandatory drug and alcohol testing conducted by transit systems and their contractors who receive funds from the Federal Transit Administration (FTA). Under the Omnibus Transportation Employee Testing Act passed by Congress in 1991, the FTA was required to establish regulations for drug and alcohol testing of transit employees performing safety-sensitive functions. These regulations require that each recipient of FTA funds: (1) implement an anti-drug program to deter and detect the use of prohibited drugs, (2) establish a program to prevent the misuse of alcohol, and (3) report the results of its programs to FTA annually. The 2019 Annual Summary summarizes the reported results of drug and alcohol tests from all such transit systems.

Compliance with FTA’s drug and alcohol testing program is a condition of federal assistance. Failure of a recipient to establish and implement a drug and alcohol testing program - either in its own operations or in those of an entity operating on its behalf - may result in the suspension of federal transit funding to the recipient. Because a recipient may not always directly provide transit services, the FTA uses the term “operator” or “employer” to describe those who provide transit services. The direct recipient of FTA funds, however, is the entity legally responsible to the FTA for compliance.